Alere Inc. (NYSE:ALR) said that it filed a lawsuit against pharmaceutical giant Abbott Laboratories (NYSE:ABT) in Delaware Chancery Court, seeking to compel Abbott to fulfill its obligations under the terms of the merger agreement to take all actions necessary to promptly obtain all required anti-trust approvals.
Alere expects the redacted version of the complaint to be publicly available next week.
Alere is a provider of health information through diagnostic tests.
Investment analysts at Berenberg upgraded Ladbrokes PLC (OTCMKTS:LDBKY) shares from a Hold to a Buy rating
Ladbrokes recently reported for the first six months of the year a pretax profit of £25.2 million compared to a loss of £54.1 million for the same period 2015.
Ladbrokes is a world leader in the betting and gaming industry with over 2,700 betting outlets in the UK, Ireland, Belgium and Spain and over 800,000 active online customers.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/